Proton pump inhibitors are associated with incident type 2 diabetes mellitus in a prospective population-based cohort study.
Petra CzarniakFariba AhmadizarJeff HughesRichard ParsonsMaryam KavousiMohammad IkramBruno H StrickerPublished in: British journal of clinical pharmacology (2021)
New users of PPIs during follow-up had a significantly higher dose-dependent risk of incident diabetes. We suggest vigilance regarding their potential adverse effect on glucose homeostasis.